Aurinia Pharmaceuticals Inc (AUPH) SEC filings
Aurinia Pharmaceuticals Inc (AUPH) SEC filings — 10-K, 10-Q, 8-K, and Form 4 as cached from EDGAR. When an exhibit lands, this page shows the headline, the numbers, and why it matters.
Those exhibit numbers sit next to the income-statement cache: Latest reported AUPH revenue for 2025-09-30 was $73.5M. Net income was $31.6M. Revenue was up 4.9% from 2025-06-30 to 2025-09-30. AUPH currently screens at market cap $1.03B and trailing P/E 28.1. The AUPH filings page is the source view; the stock page is the research view.
EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what Aurinia Pharmaceuticals Inc said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.
0
10-K
0
10-Q
0
8-K
0
Form 4
No cached SEC filings for AUPH yet. When an 8-K lands, this page will show the exhibit headline and numbers.
Open EDGAREDGAR is the official archive. Browse all AUPH filings.
Frequently asked questions
What did AUPH just say?
AUPH cached filings are listed below. Open the latest 8-K exhibit for the company’s own words.
Where are AUPH SEC filings?
0 cached filings are on this page. EDGAR remains the official archive.
What is an 8-K Item 2.02?
Item 2.02 is the earnings exhibit. Lician reads EX-99.1 for revenue, growth, EPS, and guidance — not a form-type label.